Investing.com - Nutex Health (NASDAQ: NUTX) reported fourth quarter EPS of $0.0000, better than the analyst estimate of $-0.0050. Revenue for the quarter came in at $69.7M versus the consensus estimate of $71.4M.
Nutex Health's stock price closed at $0.1000. It is down -45.8000% in the last 3 months and down -91.1600% in the last 12 months.
Nutex Health saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Nutex Health's stock price’s past reactions to earnings here.
According to InvestingPro, Nutex Health's Financial Health score is "fair performance".
Check out Nutex Health's recent earnings performance, and Nutex Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar